Left arrow Go Back

OPENING SPEECH BY THE HON. LAWRENCE GONZI PRIME MINISTER, FOR THE 8TH ANNUAL CONFERENCE OF THE INTERNATIONAL GENERIC PHARMACEUTICAL ALLIANCE – ST. JULIANS - MONDAY, 20TH JUNE 2005

PR0921
Date Icon 20/06/2005

Ladies and gentlemen, welcome!

I am deeply honoured to address such an esteemed gathering. As Malta’s Prime Minister and Minister of Finance, I take great pride in presenting the Maltese Islands as the best place where to meet, do business and discuss developments in such an important field as that of the pharmaceutical sector in particular.  

I trust that those of you who have visited us for the first time, have now discovered that Malta is much more than an ideal location for an enjoyable holiday with an exceptional historical and cultural dimension. It is also an ideal location to do business in.  

Malta’s strategic and singular position across the main Mediterranean trade routes fashioned it into a mercantile hub since ancient times.  When in 1964, Malta gained political independence a stronger emphasis was laid on economic growth.   As a fully independent state, Malta embarked on a programme envisaged to give a viable industrial policy base in the context of the then international economic developments. Maltese governments have, over the years, sought to nurture a positive and conducive business environment unencumbered by excessive bureaucracy. To sustain this, Malta, boasts of a workforce which is highly skilled, multi-lingual, diligent and very loyal.  

Our Medical School within the University of Malta, for example, is one of the oldest within the Commonwealth.  More than 500 students graduate every year in the medical, pharmaceutical and related fields.  Many continue for further studies abroad, a significant proportion of whom have excelled and are renowned world-class specialists in their domain.  Currently the number of medical practitioners registered in Malta is around 1,150.  

Various governments enacted legislation, policy instruments and set up organisations to promote, assist and enhance the country’s economic and industrial prospects. Incentives were introduced to attract towards Malta business opportunities assisted by robust company laws, education and managerial training. All these changes were made keeping in mind the most modern EU and

British legal systems. No restrictions exist on the repatriation of company profits and all incentives are guaranteed and integrated in one basic legal text – the Business Promotion Act, established by my Government in June 2001.  

At present, Malta enjoys a sound economic environment where well meaning and serious entrepreneurs can kick off a business without the risk of being disenchanted. Malta today hosts more than 200 international companies and over 6,000 international trading companies.  The manufacturing sector accounts for a quarter of Malta’s Gross Domestic Product employing 22% of the gainfully occupied population.  Foreign investments from the UK, Italy, Germany, Ireland, the United States, Iceland and from other Southern Mediterranean Countries are hosted on the island.  The presence and growth of Pharmaceutical manufacturing operations, such as Actavis, Arrow Pharm, Medichem, Amino Chemicals, Siegfried and Combino, to mention the larger investments, provides ample proof of my Government’s serious intent to attract, maintain and assist the global pharmaceutical industry to establish in Malta an operational hub, a ‘silicon-valley’ for pharmaceutical manufacturing hopefully spilling over and expanding in a research and development based knowledge and scientific community.  

This is why, ladies and gentlemen, I believe that it was extremely appropriate and indeed timely to hold this two-day conference here, right in the heart of the Mediterranean.  

Allow me to highlight the fact that the English language is not simply one of our two official languages. It is studied by all children since the age of six and commonly used as a language of parlance in families and institutions. The pharmaceutical sector can therefore appreciate our ability to comprehend the nuances found in the scientific jargon and lexicon characteristic of the industry.  

At present, Malta’s strategic position and its membership in the European Union provide the best business opportunity to manufacturers of generic pharmaceuticals operating on the Island by facilitating promotion, diffusion and penetration of their medicines in North African markets, where there are established trading routes for onward delivery.

Another competitive advantage Malta offers is that, due to its confined domestic market, the major pharmaceutical companies did not register their intellectual property in Malta.  This lack of foresight on their part in earlier times, if one may allow me to call it so, provides today a unique business opportunity.  

An added advantage is the inclusion of the Bolar provision in the Intellectual Property Legislation that permits manufacturers of generic pharmaceuticals to improve on branded medicines before the relative patent expires.   Moreover, pharmaceuticals companies benefit from low tax rates, financial and fiscal incentives and logistic advantages including the availability of ready-built factories finished to high standards.  Malta Enterprise is your first port of call for business in Malta.  I invite you to take this opportunity to acquaint yourself with these benefits and advantages.  

Ladies and Gentlemen:  

My government is committed to enhance Malta’s position as a hub of activity for manufacturing and assembling of generic pharmaceuticals as well as a research and development scientific community.  We look forward to seeing the generic pharmaceutical industry burgeoning in Malta. This will be a mutually beneficial endeavour. We believe that this sector can form the foundation upon which to build a Mediterranean Healthcare Centre of Excellence supported by Research and Development and a highly recognised Healthcare Services.  

Thank you for your attention and I wish you well during your stay and for the proceedings of this conference.

Share this Press Release Icon socials Icon socials Icon socials Icon socials

Other Press Releases:

STQARRIJA MILL-UFFIĊĊJU TAD-DEPUTAT PRIM MINISTRU U MINISTERU GĦAS-SAĦĦA  Ċertifikazzjoni internazzjonali tal-ogħla livell għad-dipartiment tar-radjoterapija fiċ-Ċentru tal-Onkoloġija Sir Anthony Mamo

PR261947

STQARRIJA MILL-UFFIĊĊJU TAD-DEPUTAT PRIM MINISTRU U MINISTERU GĦAS-SAĦĦA Ċ...

STQARRIJA MILL-MINISTERU GĦALL-EDUKAZZJONI U L-ISPORT  Aktar minn 1,800 student jiggradwaw mill-Università ta’ Malta

PR261946

STQARRIJA MILL-MINISTERU GĦALL-EDUKAZZJONI U L-ISPORT Aktar minn 1,800 stu...

More Press Releases Right arrow